Natera Form 4: CFO nets 1,250-share decrease after RSU vesting
Rhea-AI Filing Summary
Natera, Inc. (NTRA) – Form 4 filing
CFO Michael Burkes Brophy reported a routine set of transactions tied to RSU vesting and a previously adopted Rule 10b5-1 plan.
- RSU conversion: On 22 Jul 2025, 1,250 restricted stock units vested and were converted to common shares (Code M).
- Share sales: The executive sold 2,170 shares across four trades on 22-24 Jul at weighted-average prices of $139.20-$141.28 to cover tax-withholding and liquidity needs.
- Net change: Beneficial ownership fell by 1,250 shares, leaving Brophy with 70,494 common shares (<≈1.8% reduction) and 1,250 unvested RSUs.
- Plan status: All dispositions were executed under a 10b5-1 plan adopted 14 Jun 2024, limiting discretionary timing.
No other corporate events or material financial information are disclosed in this filing.
Positive
- CFO retains 70,494 shares, maintaining substantial skin in the game despite sales.
- All trades executed under a pre-planned Rule 10b5-1 arrangement, lowering insider-trading risk.
Negative
- Net reduction of 1,250 shares (≈1.8% of holding) could be seen as incremental insider selling pressure.
Insights
TL;DR: Routine RSU vesting; modest net sale by CFO is pre-planned, impact on valuation is minimal.
The filing shows a standard equity compensation event: 1,250 RSUs vested, then 2,170 shares were sold to address tax and liquidity. Because transactions occur under a previously disclosed 10b5-1 plan, they do not indicate opportunistic insider sentiment. Post-trade holdings of 70,494 shares keep the CFO highly exposed to the stock, so alignment with shareholders remains intact. Given the small volume relative to NTRA’s average daily volume and the executive’s remaining stake, we assess this disclosure as informational rather than market-moving.
TL;DR: Governance-neutral event; compliant 10b5-1 structure mitigates insider-trading concerns.
The company’s adherence to Rule 10b5-1 procedures and detailed footnote disclosure reduces legal and optics risk. Vesting schedule (25% cliff, quarterly thereafter) matches typical tech-sector patterns. Insider retains a significant position, suggesting continued commitment. We therefore classify the impact on governance perception and share-holder confidence as neutral.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 458 | $139.2028 | $64K |
| Sale | Common Stock | 297 | $139.9499 | $42K |
| Sale | Common Stock | 495 | $141.28 | $70K |
| Exercise | Restricted Stock Unit | 1,250 | $0.00 | -- |
| Sale | Common Stock | 920 | $139.5816 | $128K |
| Exercise | Common Stock | 1,250 | $0.00 | -- |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on October 22, 2021. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.62 to $139.59 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.71 to $140.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
